Duke University's Center for Human Genetics Selects Illumina's Infinium HumanHap550 BeadChip for Landmark Autism Study.
Illumina Inc. announced that Duke University's Center for Human Genetics (CHG) has selected the Infinium HumanHap550 BeadChip for an Autism study of over 1,800 individuals and their families. The identification of the genes which contribute to complex disease like autism will lead to the development of enhanced diagnostic tools, early detection, and improved health outcomes for patients and their families. Drs. Margaret Pericak-Vance and John R. Gilbert will lead the Duke CHG team of autism researchers.
